Shire sues Roxane, Watson on generic ADHD drug
Vyvanse is a prescription medicine which is used to treat attention deficit hyperactivity disorder (ADHD) in adults and in children who are at least 6 years old. Shire
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.